TENULI Trademark
TENULI is a USPTO trademark filed by Bausch Health Ireland Limited. Status: Registered.
Trademark Facts
| Mark | TENULI |
|---|---|
| Serial Number | 79429970 |
| Registration Number | 8200422 |
| Status | Registered |
| Filing Date | 2025-07-11 |
| Registration Date | 2026-04-07 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Bausch Health Ireland Limited |
| Attorney of Record | Jeremy Blackowicz |
| Prosecution Events | 19 |
| Latest Event | R.PR on 2026-04-07 |
Goods & Services
Class 005: Pharmaceutical preparations and substances; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-17 | OG Publication Confirmation | PB3 |
| 2026-02-11 | Notification of Notice of Publication | EB4 |
| 2026-02-11 | Notice of Publication | PB1 |
| 2026-01-29 | IB-Processed Transaction | MID |
| 2026-01-22 | TRAM Snapshot of App at Pub for Oppostn | PST |
| 2026-01-13 | Amendment and Mail Process Complete | AMC |
USPTO Refusals on Record
- counsel_advisory
- indefinite_identification